(ICL) ICL Israel Chemicals - Ratings and Ratios
Bromine, Potash, Phosphate, Fertilizers, Flame Retardants
ICL EPS (Earnings per Share)
ICL Revenue
Description: ICL ICL Israel Chemicals November 03, 2025
ICL Group Ltd (NYSE:ICL) is a vertically integrated specialty minerals and chemicals producer operating worldwide through four business segments: Industrial Products (bromine, magnesium, flame retardants), Potash (potash, salt, magnesium alloys and by-products), Phosphate Solutions (phosphate fertilizers, green phosphoric acid, functional food ingredients) and Growing Solutions (nitrogen-potash-phosphate fertilizers, bio-stimulants, digital agronomy platforms). The firm serves a broad customer base spanning agriculture, pharma, construction, electronics, automotive, and energy-related industries.
In FY 2023 ICL reported revenue of roughly $7.2 billion and an adjusted EBITDA margin of 18.5%, with a dividend yield near 3.2% and a payout ratio of 70%. The Potash segment contributed about 45% of total sales, driven by an average realized potash price of $460 per metric ton, while the Growing Solutions segment grew sales 12% YoY, reflecting strong demand for specialty and controlled-release fertilizers. ICL’s annual potash production capacity stands at ~5.5 million metric tons, positioning it among the top-five global potash exporters.
The company’s outlook is closely tied to macro-level fertilizer demand, which is projected to rise 3–4% annually over the next decade as global population approaches 10 billion and dietary shifts increase per-capita grain consumption. Supply-side constraints-particularly in Russia and Belarus-have historically supported higher potash and phosphate prices, while ESG pressures are prompting growers to adopt higher-efficiency, lower-environmental-impact products, a niche where ICL’s specialty fertilizers and digital agronomy tools have a competitive edge.
For a deeper, data-driven assessment of ICL’s valuation dynamics and scenario analysis, you may find the research dashboards on ValueRay worth exploring.
ICL Stock Overview
| Market Cap in USD | 8,490m |
| Sub-Industry | Fertilizers & Agricultural Chemicals |
| IPO / Inception | 2014-09-24 |
ICL Stock Ratings
| Growth Rating | 25.8% |
| Fundamental | 44.5% |
| Dividend Rating | 52.9% |
| Return 12m vs S&P 500 | 27.6% |
| Analyst Rating | 3.0 of 5 |
ICL Dividends
| Dividend Yield 12m | 2.71% |
| Yield on Cost 5y | 7.00% |
| Annual Growth 5y | 20.81% |
| Payout Consistency | 71.7% |
| Payout Ratio | 68.7% |
ICL Growth Ratios
| Growth Correlation 3m | 61.9% |
| Growth Correlation 12m | 71.3% |
| Growth Correlation 5y | -3.1% |
| CAGR 5y | -3.02% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.06 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.12 |
| Sharpe Ratio 12m | -0.12 |
| Alpha | 42.98 |
| Beta | 1.111 |
| Volatility | 31.35% |
| Current Volume | 383.8k |
| Average Volume 20d | 454.9k |
| Stop Loss | 6.3 (-4.4%) |
| Signal | 0.00 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (367.0m TTM) > 0 and > 6% of Revenue (6% = 417.2m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -2.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 26.02% (prev 19.75%; Δ 6.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 1.26b > Net Income 367.0m (YES >=105%, WARN >=100%) |
| Net Debt (2.33b) to EBITDA (1.44b) ratio: 1.62 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.75 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.29b) change vs 12m ago 0.15% (target <= -2.0% for YES) |
| Gross Margin 32.29% (prev 32.27%; Δ 0.01pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 58.97% (prev 63.48%; Δ -4.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.05 (EBITDA TTM 1.44b / Interest Expense TTM 277.0m) >= 6 (WARN >= 3) |
Altman Z'' 4.02
| (A) 0.15 = (Total Current Assets 4.24b - Total Current Liabilities 2.43b) / Total Assets 12.38b |
| (B) 0.47 = Retained Earnings (Balance) 5.84b / Total Assets 12.38b |
| (C) 0.07 = EBIT TTM 845.0m / Avg Total Assets 11.79b |
| (D) 0.99 = Book Value of Equity 6.03b / Total Liabilities 6.11b |
| Total Rating: 4.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 44.45
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 4.09% = 2.05 |
| 3. FCF Margin 6.30% = 1.57 |
| 4. Debt/Equity 0.48 = 2.38 |
| 5. Debt/Ebitda 1.62 = 0.74 |
| 6. ROIC - WACC (= -1.55)% = -1.94 |
| 7. RoE 6.26% = 0.52 |
| 8. Rev. Trend -76.73% = -5.75 |
| 9. EPS Trend -82.64% = -4.13 |
What is the price of ICL shares?
Over the past week, the price has changed by -0.75%, over one month by +2.81%, over three months by +10.22% and over the past year by +53.05%.
Is ICL Israel Chemicals a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ICL is around 6.57 USD . This means that ICL is currently overvalued and has a potential downside of -0.3%.
Is ICL a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ICL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.6 | -0.5% |
| Analysts Target Price | 6.6 | -0.5% |
| ValueRay Target Price | 7.3 | 10.8% |
ICL Fundamental Data Overview November 04, 2025
P/E Trailing = 22.4828
P/S = 1.221
P/B = 1.3435
P/EG = 9.44
Beta = 1.111
Revenue TTM = 6.95b USD
EBIT TTM = 845.0m USD
EBITDA TTM = 1.44b USD
Long Term Debt = 2.55b USD (from longTermDebt, last quarter)
Short Term Debt = 365.0m USD (from shortTermDebt, last quarter)
Debt = 2.92b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.33b USD (from netDebt column, last quarter)
Enterprise Value = 10.70b USD (8.49b + Debt 2.92b - CCE 701.0m)
Interest Coverage Ratio = 3.05 (Ebit TTM 845.0m / Interest Expense TTM 277.0m)
FCF Yield = 4.09% (FCF TTM 438.0m / Enterprise Value 10.70b)
FCF Margin = 6.30% (FCF TTM 438.0m / Revenue TTM 6.95b)
Net Margin = 5.28% (Net Income TTM 367.0m / Revenue TTM 6.95b)
Gross Margin = 32.29% ((Revenue TTM 6.95b - Cost of Revenue TTM 4.71b) / Revenue TTM)
Gross Margin QoQ = 30.24% (prev 31.69%)
Tobins Q-Ratio = 0.86 (Enterprise Value 10.70b / Total Assets 12.38b)
Interest Expense / Debt = 3.36% (Interest Expense 98.0m / Debt 2.92b)
Taxrate = 35.71% (60.0m / 168.0m)
NOPAT = 543.2m (EBIT 845.0m * (1 - 35.71%))
Current Ratio = 1.75 (Total Current Assets 4.24b / Total Current Liabilities 2.43b)
Debt / Equity = 0.48 (Debt 2.92b / totalStockholderEquity, last quarter 6.01b)
Debt / EBITDA = 1.62 (Net Debt 2.33b / EBITDA 1.44b)
Debt / FCF = 5.33 (Net Debt 2.33b / FCF TTM 438.0m)
Total Stockholder Equity = 5.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.97% (Net Income 367.0m / Total Assets 12.38b)
RoE = 6.26% (Net Income TTM 367.0m / Total Stockholder Equity 5.86b)
RoCE = 10.04% (EBIT 845.0m / Capital Employed (Equity 5.86b + L.T.Debt 2.55b))
RoIC = 6.53% (NOPAT 543.2m / Invested Capital 8.32b)
WACC = 8.08% (E(8.49b)/V(11.40b) * Re(10.11%) + D(2.92b)/V(11.40b) * Rd(3.36%) * (1-Tc(0.36)))
Discount Rate = 10.11% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.06%
[DCF Debug] Terminal Value 66.63% ; FCFE base≈524.7m ; Y1≈420.8m ; Y5≈287.2m
Fair Price DCF = 2.99 (DCF Value 3.86b / Shares Outstanding 1.29b; 5y FCF grow -23.71% → 3.0% )
EPS Correlation: -82.64 | EPS CAGR: -70.61% | SUE: -4.0 | # QB: 0
Revenue Correlation: -76.73 | Revenue CAGR: -10.93% | SUE: 1.92 | # QB: 2
Additional Sources for ICL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle